Tovinontrine Phase 2 Trial: Lower Doses Cut NT-proBNP
Tovinontrine Phase 2 trial: two of three doses cut NT-proBNP in 529 heart failure patients, but the top dose did not. What it shows and what it does not.
NEET PG Counselling 2026: Round 1 Registration Oct 12-21
NEET PG counselling 2026 round 1 registration is scheduled for 12 to 21 October. Dates, fees, documents and steps, plus what to verify on the MCC site.
Emcure Pharmaceuticals Merger 2026: 2 Units Fold In
Emcure Pharmaceuticals merger 2026: board approves folding wholly owned Zuventus and Emcutix into the parent. No new shares; NCLT approval is needed.
AI Drug Discovery India: ₹86 Crore Boost for Peptris
AI drug discovery India gets a boost as TDB backs Peptris with ₹86 crore to move four AI-found drug candidates toward the clinic. Terms and unknowns.
Bayer GLP-1 India Plan: Eyes 3x Revenue by 2030
Bayer GLP-1 India plan: the company is assessing consumer-health products for GLP-1 side effects and aims to triple India revenue by 2030.
GI Cancer in Young People India: Patients as Young as 15
GI cancer in young people India: Delhi doctors report patients as young as 15. A 2026 review links air pollution, but cause is unproven.
Lancet Global Health Threats 2026: 17 Alarming Risks by 2100
Lancet global health threats 2026: a commission names 17 risks to 2100, from malicious AI and nuclear conflict to pandemics. Key numbers and findings.
Pope Leo XIV Lung Surgery: Early Nodule, 1-Week Recovery
Pope Leo XIV lung surgery set after doctors found an early-stage nodule. What the Vatican said, what is unknown and what a lung nodule means.
Kenya Ebola Outbreak October 2026: 0 New Cases in 293 Tests
Kenya Ebola outbreak October 2026 update: no new cases after 293 tests, 108 contacts in quarantine, as the Congo outbreak continues.
Philips Sleep Apnea Device Recall: 15M Units, Court Win
Philips sleep apnea device recall: a Dutch court rejected shareholders’ bid for an inquiry. What it means for 15 million devices and patients.